The methanol extract of Guettarda speciosa Linn. Ameliorates acute lung injury in mice.
Acute Lung Injury
/ drug therapy
Animals
Anti-Inflammatory Agents
/ pharmacology
Chromatography, Liquid
Disease Models, Animal
Flow Cytometry
Leukocyte Elastase
/ metabolism
Lipopolysaccharides
Lung
/ drug effects
Male
Methanol
Mice
Mice, Inbred C57BL
NF-E2-Related Factor 2
/ metabolism
NF-kappa B
/ metabolism
Plant Extracts
/ pharmacology
Pneumonia
/ drug therapy
Rubiaceae
/ chemistry
Acute lung injury
Anti-inflammation
Guettarda speciosa Linn.
NF-κB
Neutrophil elastase
Nrf2
Journal
BMC complementary medicine and therapies
ISSN: 2662-7671
Titre abrégé: BMC Complement Med Ther
Pays: England
ID NLM: 101761232
Informations de publication
Date de publication:
07 Feb 2020
07 Feb 2020
Historique:
received:
25
10
2019
accepted:
23
01
2020
entrez:
9
2
2020
pubmed:
9
2
2020
medline:
18
8
2020
Statut:
epublish
Résumé
Guettarda speciosa is mainly found in tropical areas in Asia. Although G. speciosa is traditionally used to treat some of the inflammatory disorders, the experimental evidence supporting the anti-inflammatory effect of G. speciosa is limited. Here, we sought to obtain evidence that G. speciosa has anti-inflammatory activity using an acute lung injury (ALI) mouse model and to explore possible underlying mechanisms for the activity. The methanol extract of G. speciosa Linn. (MGS) was fingerprinted by HPLC. Cytotoxicity was determined by MTT and flow cytometer. As for an ALI mouse model, C57BL/6 mice received an intratracheal (i.t.) injection of lipopolysaccharide (LPS). The effects of MGS on lung inflammation in the ALI mice were assessed by differential cell counting and FACS of inflammatory cells and hematoxylin and eosin staining of lung tissue. Proteins were analyzed by immunoprecipitation and immunoblotting, and gene expression was by real-time qPCR. Neutrophil elastase activity was measured by ELISA. MGS did not cause metabolic disarray or produce reactive oxygen species that could induce cytotoxicity. Similar to ALI patients, C57BL/6 mice that received an i.t. LPS developed a high level of neutrophils, increased pro-inflammatory cytokines, and inflicted tissue damage in the lung, which was suppressed by i.t. MGS administered at 2 h after LPS. Mechanistically, MGS activated Nrf2, which was related to MGS interrupting the ubiquitin-dependent degradation of Nrf2. MGS suppressed the nuclear localization of NF-κB induced by LPS, suggesting the inhibition of NF-κB activity. Furthermore, MGS inhibited the enzymatic activity of neutrophil elastase. MGS could suppress lung inflammation in an ALI mouse model, the effect of which could be attributed to multiple mechanisms, including the activation of Nrf2 and the suppression of NF-κB and neutrophil elastase enzymatic activity by MGS.
Sections du résumé
BACKGROUND
BACKGROUND
Guettarda speciosa is mainly found in tropical areas in Asia. Although G. speciosa is traditionally used to treat some of the inflammatory disorders, the experimental evidence supporting the anti-inflammatory effect of G. speciosa is limited. Here, we sought to obtain evidence that G. speciosa has anti-inflammatory activity using an acute lung injury (ALI) mouse model and to explore possible underlying mechanisms for the activity.
METHODS
METHODS
The methanol extract of G. speciosa Linn. (MGS) was fingerprinted by HPLC. Cytotoxicity was determined by MTT and flow cytometer. As for an ALI mouse model, C57BL/6 mice received an intratracheal (i.t.) injection of lipopolysaccharide (LPS). The effects of MGS on lung inflammation in the ALI mice were assessed by differential cell counting and FACS of inflammatory cells and hematoxylin and eosin staining of lung tissue. Proteins were analyzed by immunoprecipitation and immunoblotting, and gene expression was by real-time qPCR. Neutrophil elastase activity was measured by ELISA.
RESULTS
RESULTS
MGS did not cause metabolic disarray or produce reactive oxygen species that could induce cytotoxicity. Similar to ALI patients, C57BL/6 mice that received an i.t. LPS developed a high level of neutrophils, increased pro-inflammatory cytokines, and inflicted tissue damage in the lung, which was suppressed by i.t. MGS administered at 2 h after LPS. Mechanistically, MGS activated Nrf2, which was related to MGS interrupting the ubiquitin-dependent degradation of Nrf2. MGS suppressed the nuclear localization of NF-κB induced by LPS, suggesting the inhibition of NF-κB activity. Furthermore, MGS inhibited the enzymatic activity of neutrophil elastase.
CONCLUSION
CONCLUSIONS
MGS could suppress lung inflammation in an ALI mouse model, the effect of which could be attributed to multiple mechanisms, including the activation of Nrf2 and the suppression of NF-κB and neutrophil elastase enzymatic activity by MGS.
Identifiants
pubmed: 32033557
doi: 10.1186/s12906-020-2828-6
pii: 10.1186/s12906-020-2828-6
pmc: PMC7076890
doi:
Substances chimiques
Anti-Inflammatory Agents
0
Lipopolysaccharides
0
NF-E2-Related Factor 2
0
NF-kappa B
0
Nfe2l2 protein, mouse
0
Plant Extracts
0
Leukocyte Elastase
EC 3.4.21.37
Methanol
Y4S76JWI15
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
40Subventions
Organisme : Ministry of Education, Science and Technology
ID : NRF-2017R1A2B4005357
Organisme : Ministry of Education, Science and Technology
ID : 2014R1A5A2009936
Références
J Clin Invest. 2006 Apr;116(4):984-95
pubmed: 16585964
Nat Immunol. 2004 Oct;5(10):971-4
pubmed: 15454919
Ann N Y Acad Sci. 2008 Dec;1147:61-9
pubmed: 19076431
Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12731-6
pubmed: 10535991
N Engl J Med. 2003 Jan 9;348(2):138-50
pubmed: 12519925
Sci Rep. 2016 Jul 15;6:29956
pubmed: 27417293
Cell. 2002 Apr;109 Suppl:S81-96
pubmed: 11983155
BMC Complement Altern Med. 2019 Jan 10;19(1):15
pubmed: 30630473
Trends Mol Med. 2011 Jul;17(7):363-71
pubmed: 21459041
J Clin Invest. 2004 Nov;114(9):1248-59
pubmed: 15520857
Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):250-5
pubmed: 19104057
Glia. 2006 Jun;53(8):891-901
pubmed: 16609961
Free Radic Biol Med. 2017 Dec;113:48-58
pubmed: 28939422
J Exp Med. 2005 Jul 4;202(1):47-59
pubmed: 15998787
Clin Chest Med. 2005 Mar;26(1):105-12
pubmed: 15802172
Int J Mol Med. 2018 Mar;41(3):1783-1791
pubmed: 29328440
N Engl J Med. 2000 May 4;342(18):1334-49
pubmed: 10793167
Histol Histopathol. 1999 Apr;14(2):511-6
pubmed: 10212813
Cell. 2017 Jan 12;168(1-2):37-57
pubmed: 28086098
Cardiovasc Res. 2009 Jul 15;83(2):354-61
pubmed: 19351736
Intern Med. 2009;48(9):621-30
pubmed: 19420806
Curr Top Microbiol Immunol. 2002;270:109-20
pubmed: 12467247
Annu Rev Biochem. 2016 Jun 2;85:765-92
pubmed: 27050287
Biochim Biophys Acta Mol Basis Dis. 2017 Feb;1863(2):585-597
pubmed: 27825853
J Biol Chem. 2005 Aug 26;280(34):30091-9
pubmed: 15983046
Free Radic Biol Med. 2013 Dec;65:1134-1142
pubmed: 24029383
Eur J Pharmacol. 2002 Sep 6;451(1):1-10
pubmed: 12223222
Free Radic Biol Med. 2014 Jan;66:36-44
pubmed: 23434765
Evid Based Complement Alternat Med. 2013;2013:659459
pubmed: 24062787
J Vis Exp. 2009 Jul 02;(29):
pubmed: 19574953
J Pathol. 2004 Feb;202(2):145-56
pubmed: 14743496
N Engl J Med. 2005 Oct 20;353(16):1685-93
pubmed: 16236739
J Immunol. 2005 Apr 1;174(7):4345-55
pubmed: 15778399
Int J Biochem Cell Biol. 2008;40(6-7):1317-33
pubmed: 18180196
Evid Based Complement Alternat Med. 2013;2013:863892
pubmed: 23983806
Semin Immunol. 2014 Jun;26(3):253-66
pubmed: 24958609
Clin Infect Dis. 1992 Jun;14(6):1213-28
pubmed: 1623078
J Biol Chem. 1999 Sep 10;274(37):26071-8
pubmed: 10473555
Mol Cancer. 2013 Aug 02;12:86
pubmed: 23915189
Neuroscience. 2007 Jun 15;147(1):53-9
pubmed: 17507167